Thursday

Video: What works, What Doesn’t

What works and what doesn't work in Parkinson's? We asked four experts in the field for their take:Mahlon R. DeLong, MD, professor of neurology at the Emory University School of Medicine in Atlanta; C. Warren Olanow, MD, chairman emeritus and professor in the department of neurology at the Icahn School of Medicine at Mount Sinai in New York City; Mark Stacy, MD, professor of neurology at Duke University; and David Standaert, MD, PhD, professor and chair of the department of neurology at the University of Alabama at Birmingham. In this video, they discussed surgical interventions, levodopa as the "gold standard," managing disease, the role of exercise, and biomarkers for disease progression. Challenges include looking past levodopa and moving from laboratory targets to drugs.

Click to watch video